Navigation Links
Egenix, Inc. Appoints Dr. Daniel Petrylak Chairman of Scientific Advisory Board
Date:4/8/2008

MILLBROOK, N.Y., April 8, 2008 /PRNewswire/ -- Donald C. Fresne, Chairman and CEO, Egenix, Inc., announced the appointment of Daniel Petrylak, MD as Chairman of the company's scientific advisory board. Dr. Petrylak is currently Associate Professor of Medicine at Columbia University Medical Center where he is Director of Genitourinary Oncology, Division of Medical Oncology. He is the co-author of numerous peer reviewed scientific papers and is a national leader in the treatment of cancers of prostate, kidney, and bladder. Dr. Petrylak stated, "I enthusiastically look forward to working with the Egenix team. I believe the company's initiatives for development of targeted translation inhibitors will reach the clinic in a timely fashion and provide unique benefits for patients with cancer."

About Egenix, Inc.

Based in Millbrook, New York, Egenix, Inc. is a privately held biotechnology company responding to the demand for more effective cancer therapies. Egenix is developing small molecule inhibitors of translation initiation, a new paradigm in target-specific, non-cytotoxic anti-cancer therapy, and the use of translation initiation-specific biomarkers to assess tumor sensitivity to anti-cancer therapy with this novel class of anti-cancer drugs.


'/>"/>
SOURCE Egenix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director
2. Observant LLC Appoints Two New Directors to the Senior Management Team
3. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
4. Light Sciences Oncology Appoints David P. Holveck to Its Board of Directors
5. IDM Pharma Appoints Gregory J. Tibbitts to Board of Directors
6. Caliper Life Sciences Appoints Peter F. McAree Senior Vice President and Chief Financial Officer
7. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
8. Touch Bionics appoints Head of Clinical Advocacy
9. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
10. Neurobiological Technologies Appoints Matthew M. Loar as Chief Financial Officer
11. NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Symic Bio, a biopharmaceutical company focused on ... therapeutics, announced today the completion of enrollment for the ... The trial will evaluate the safety and efficacy of ... of restenosis following angioplasty. "We,re pleased ... said Nathan Bachtell , M.D., Chief Medical Officer ...
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or ... China, today announced its financial results for the fourth quarter ... 2016 Financial Highlights Total sales in ... terms, or increased by 13.6% in USD terms to $77.6 ... Gross profit increased by 13.3% to $46.8 ...
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
Breaking Biology Technology:
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
(Date:2/6/2017)... 2017 According to Acuity Market Intelligence, ... authorities to continue to embrace biometric and digital ... Automated Border Control (ABC) eGates and 1436 Automated ... than 163 ports of entry across the globe. ... a combined CAGR of 37%. APC Kiosks reached ...
Breaking Biology News(10 mins):